scholarly journals 813 Incidence and Indicators of Suboptimal Response to Tumor Necrosis Factor Antagonist Therapy in Inflammatory Bowel Disease in Newly Industrialized Countries: Results From the EXPLORE Study

2019 ◽  
Vol 114 (1) ◽  
pp. S470-S470
Author(s):  
Othman Al Harbi ◽  
Alessandro Armuzzi ◽  
Webber Chan ◽  
Enrique Ponce de Leon ◽  
Jiaming Qian ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Industrialized Countries ◽  
Tumor Necrosis Factor Antagonist ◽  
Antagonist Therapy ◽  
Newly Industrialized Countries ◽  
Inflammatory Bowel ◽  
Factor Antagonist ◽  
Necrosis Factor

scholarly journals Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease

2017 ◽  
Vol 49 (10) ◽  
pp. 1086-1091 ◽  
Author(s):  
James O. Lindsay ◽  
Alessandro Armuzzi ◽  
Javier P. Gisbert ◽  
Bernd Bokemeyer ◽  
Laurent Peyrin-Biroulet ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Tumor Necrosis Factor ◽  
Bowel Disease ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Antagonist ◽  
Antagonist Therapy ◽  
Inflammatory Bowel ◽  
Factor Antagonist ◽  
Necrosis Factor

scholarly journals Refractory Lymphocytic Enterocolitis and Tumor Necrosis Factor Antagonist Therapy

2010 ◽  
Vol 8 (4) ◽  
pp. 391-394 ◽  
Author(s):  
Ghazaleh Aram ◽  
Theodore M. Bayless ◽  
Zong–Ming Chen ◽  
Elizabeth A. Montgomery ◽  
Mark Donowitz ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Antagonist ◽  
Antagonist Therapy ◽  
Factor Antagonist ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document